1,882 results on '"Reginster, J.-Y."'
Search Results
2. Intrinsic capacity and risk of death: Focus on the impact of using different diagnostic criteria for the nutritional domain
3. In Memoriam: Lorie Fitzpatrick MD — 1954–2023
4. Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment
5. Intrinsic Capacity Defined Using Four Domains and Mortality Risk: A 5-Year Follow-Up of the SarcoPhAge Cohort
6. The Role of Nutrition in Bone Health
7. How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
8. Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL
9. An Assessment of the Toulouse Saint Louis University Mini Falls Assessment Tool to Predict Incident Falls among Older Adults Residing in Nursing Homes: A 6-Month Prospective Study
10. Determining individual trajectories of joint space loss: improved statistical methods for monitoring knee osteoarthritis disease progression
11. How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
12. Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement
13. Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
14. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
15. Erratum to: Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines
16. Clinical Impact of Nutritional Status and Energy Balance in Elderly Hospitalized Patients
17. Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time Horizon
18. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
19. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
20. Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines
21. Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
22. Using health-economic evidence to support policy-level decision-making in Singapore—sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds
23. Traduction en langue française, adaptation transculturelle et validation du questionnaire « Victorian Institute of Sport Assessment Scale for Proximal Hamstring Tendinopathy » (VISA-H)
24. Impact of whole dairy matrix on musculoskeletal health and aging–current knowledge and research gaps
25. Alternative and complementary therapies in osteoarthritis and cartilage repair
26. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
27. Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women
28. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
29. How to Implement a Fracture Liaison Service
30. In memoriam: Vladyslav Povoroznyuk
31. Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
32. Impact of frailty status on the cost of drugs and dietary supplements prescribed to nursing home residents: the SENIOR cohort
33. Bone metabolism markers are associated with neck circumference in adult Arab women
34. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women
35. Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
36. Effect of acute downhill running on bone markers in responders and non-responders
37. Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
38. The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies
39. Phosphate wasting disorders in adults
40. Discriminative Power of the Sarcopenia Quality of Life (SarQoL®) Questionnaire with the EWGSOP2 Criteria
41. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women
42. Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation
43. Assessing gait parameters with accelerometer-based methods to identify older adults at risk of falls: a systematic review
44. Subjective Sleep Quality among Sarcopenic and Non-Sarcopenic Older Adults: Results from the Sarcophage Cohort
45. Review of the guideline of the American College of Physicians on the treatment of osteoporosis
46. Understanding osteoporotic pain and its pharmacological treatment
47. Bone health assessment in older people with or without muscle health impairment
48. Osteoarthritis Increases the Risk of Cardiovascular Disease: Data from the Osteoarthritis Initiative
49. Effects of Protein, Essential Amino Acids, B-Hydroxy B-Methylbutyrate, Creatine, Dehydroepiandrosterone and Fatty Acid Supplementation on Muscle Mass, Muscle Strength and Physical Performance in Older People Aged 60 Years and Over. A Systematic Review of the Literature
50. Pro-inflammatory dietary pattern is associated with fractures in women: an eight-year longitudinal cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.